Non-Hodgkin Lymphoma after Acute Myocardial Infarction: A Case Report
Article Sidebar
Main Article Content
Abstract
Acute myocardial infarction (MI) has never been mentioned as the risk factor for Non-Hodgkin lymphoma (NHL) development. But both of them may have some risk factors in common. Herein we report a case of 43-year-old Thai man who was diagnosed as acute inferior wall myocardial infarction based on the findings of the pathologic Q waves in leads II, III, aVF and coronary thrombosis on angiography three years ago. His risk factors consisted of hyperlipidemia, hypertension and long term smoking. He was successfully treated with the coronary intervention and medicated stenting and his regular medications includeda spirin, atenolol, amlodipine, gemfibrozil, losartan and ranitidine. He had been well until developed progressive cervical lymph nodes enlargement for one month without fever or significant weight loss. And also multiple lymphadenopathies were found in the chest on the computerized tomogram of the chest. The cervical lymph node biopsy showed diffuse large B cell lymphoma. His clinical diagnosis was NHL stage IIA and he was treated with chemotherapy, CHOP regimen. He responded well to treatment, no relapse of NHL or acute MI. Although the direct association between acute MI and NHL has never been mentioned, both have one risk factor in common that is the current smoking.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Delmas-Marsalet B, Molinie V, Jary L, Teillet-Thiebaud F, Estagnasie P, Barge J, et al. Cardiac localization of non-Hodgkin's lymphoma: two case reports and review of literature. Nouv Rev Fr Hematol 1995; 37:2223-30.
Meng Q, Lai H, Lima J, Tong W, Qian Y, Lai S. Echocardiographic and pathological characteristics of cardiac metastasis in patients with lymphoma. Oncol Rep 2002; 9: 85-8.
Konety SH, Wooldridge JE, Kerber RE. Primary cardiac non-Hodgkin's lymphoma diagnosed by transthoracic echocardiography. Echocardiography 2006; 23: 147-8.
Harris S, Waddell J. Non-Hodgkin's lymphoma: an unusual cause of myocardial infarction and hypercalcaemia. Clin Oncol (R Coll Radiol) 1993; 5: 189-90.
Anand SS,Islam S,Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008; 29: 932-40.Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathol 2005; 37:409-19.
Yusuf S, Hawken S, OunpuuS, DansT, AvezumA, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries(the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
Balasubramaniam G, Saoba S, Sarade M, Pinjare S. Case-control study of risk factors for Non-Hodgkin Lymphoma in Mumbai, India. Asian Pac J Cancer Prev 2013; 14: 775-80.
Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the international Iymphoma epidemiology "consortium (Inter Lymph). Cancer Epidemiol Biomarkers Prev 2005; 14: 925-33.
Mitri J, Castillo J, Pittas AG. Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies. Diabetes Care 2008; 31:2391-7.
Cerhan JR, Anderson KE, Janney CA, Vachon CM, Witzig TE, Habermann TM. Association of
aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer 2003; 106: 784-8.
Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006; 54: 692-701.
Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L. Risk of non-Hodgkin Iymphoma and use of non-steroidal anti-inflammatory drugs. Cancer Detect Prev 2006; 30: 99-101.
Flick ED, Chan KA, Bracci PM, Holly EA. Use of nonsteroidalantinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study. Am J Epidemiol 2006; 164: 497-504.
Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, et al. Association of aspirin and nonaspirinnonsteroidal anti-inflammatory drugs with cancer incidence and mortality. J Natl Cancer Inst 2007; 99: 881-9.
Baker JA, Weiss JR, Czuczman MS, Menezes RJ, Ambrosone CB, Moysich KB. Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control 2005; 16:301-8.
Chang ET, Cronin-Fenton DP, Friis S, Hjalgrim H, Toft Sr'rensen H, Pedersen L. Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin Lymphoma risk in Northem Denmark. Cancer Epidemiol Bioma-kers Prev 2010; 19; 59-64.